Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A randomized Controlled Trial

Previously, corticosteroid was considered as the conventional treatment for radiation-induced brain necrosis. By conducting this randomized Controlled Trial, we found that bevacizumab monotherapy, at the two-month point, offers improved symptomatic relief and radiographic response than corticosteroids.

https://ift.tt/2rmnqUb